[EN] THERAPEUTIC THIAZOLIDINONE COMPOUNDS<br/>[FR] COMPOSÉS DE THIAZOLIDINONE THÉRAPEUTIQUES
申请人:MERCK SHARP & DOHME
公开号:WO2014099834A1
公开(公告)日:2014-06-26
Thiazolidinone compounds, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.